NIRMATRELVIR AND RITONAVIR

NIRMATRELVIR AND RITONAVIR was reported 53956 times

NIRMATRELVIR AND RITONAVIR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DISEASE RECURRENCE 20106 0.4222
1 ASYMPTOMATIC COVID-19 70 0.1781
2 SYMPTOM RECURRENCE 994 0.1659
3 COVID-19 22833 0.1300
4 SARS-COV-2 TEST NEGATIVE 73 0.1081
5 DYSGEUSIA 7364 0.0990
6 CONTRAINDICATED PRODUCT PRESCRIBED 130 0.0773
7 POST-ACUTE COVID-19 SYNDROME 84 0.0678
8 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 190 0.0575
9 TASTE DISORDER 1049 0.0517
10 PRODUCT DOSE CONFUSION 17 0.0479
11 SARS-COV-2 TEST POSITIVE 630 0.0477
12 UPPER RESPIRATORY TRACT CONGESTION 135 0.0466
13 PRODUCT TASTE ABNORMAL 566 0.0418
14 HYPOTENSIVE CRISIS 6 0.0417
15 PRODUCT PRESCRIBING ERROR 973 0.0408
16 BREAKTHROUGH COVID-19 9 0.0391
17 PRODUCT BLISTER PACKAGING ISSUE 39 0.0375
18 INCORRECT PRODUCT ADMINISTRATION DURATION 737 0.0340
19 INTERCEPTED PRODUCT PRESCRIBING ERROR 44 0.0332
20 CORONAVIRUS TEST POSITIVE 32 0.0311
21 PRODUCT AFTER TASTE 29 0.0304
22 REBOUND EFFECT 342 0.0302
23 FAECES PALE 67 0.0301
24 LABELLED DRUG-DRUG INTERACTION ISSUE 40 0.0276
25 PRODUCT SIZE ISSUE 147 0.0273
26 TONGUE ERYTHEMA 21 0.0255
27 PRODUCT PACKAGING CONFUSION 59 0.0243
28 NASAL CONGESTION 1368 0.0233
29 TONGUE COATED 39 0.0226
30 CONTRAINDICATED PRODUCT ADMINISTERED 676 0.0223
31 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 134 0.0217
32 SHOCK SYMPTOM 8 0.0216
33 SNEEZING 478 0.0213
34 SINUS PAIN 48 0.0206
35 PARANASAL SINUS DISCOMFORT 70 0.0185
36 DRAINAGE 9 0.0183
37 PRODUCT CONFUSION 14 0.0176
38 RHINORRHOEA 1091 0.0169
39 PNEUMONIA HAEMOPHILUS 8 0.0165
40 PRODUCT USE COMPLAINT 254 0.0161
41 ANOSMIA 230 0.0159
42 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1082 0.0152
43 PRODUCT LABEL CONFUSION 88 0.0151
44 PRODUCT EXPIRATION DATE ISSUE 21 0.0150
45 AGEUSIA 364 0.0146
46 DYSCHEZIA 44 0.0144
47 PRODUCT DISPENSING ERROR 310 0.0142
48 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 125 0.0141
49 SINUS CONGESTION 188 0.0139
50 OROPHARYNGEAL PAIN 1251 0.0135
51 SACRAL PAIN 8 0.0132
52 HYPERTENSIVE URGENCY 7 0.0126
53 PLICATED TONGUE 6 0.0126
54 TONGUE DISCOMFORT 50 0.0118
55 PHARYNGEAL SWELLING 115 0.0117
56 SUSPECTED COVID-19 38 0.0115
57 BREATH ODOUR 28 0.0115
58 INTERCEPTED PRODUCT DISPENSING ERROR 19 0.0115
59 SINUSITIS BACTERIAL 12 0.0114
60 PAROSMIA 84 0.0111
61 ANAL INFLAMMATION 7 0.0110
62 NEAR DEATH EXPERIENCE 36 0.0109
63 TONGUE DISCOLOURATION 47 0.0107
64 UPPER-AIRWAY COUGH SYNDROME 88 0.0107
65 POOR QUALITY PRODUCT ADMINISTERED 109 0.0103
66 ANORECTAL DISCOMFORT 54 0.0101
67 DRUG LEVEL INCREASED 166 0.0100
68 LIP ERYTHEMA 8 0.0100
69 RESPIRATORY TRACT CONGESTION 156 0.0098
70 RESPIRATORY SYMPTOM 27 0.0095
71 INCREASED VISCOSITY OF BRONCHIAL SECRETION 6 0.0094
72 VOMITING PROJECTILE 25 0.0086
73 DYSBIOSIS 7 0.0085
74 SYNDACTYLY 7 0.0084
75 REFLUX GASTRITIS 10 0.0083
76 FOREIGN BODY IN THROAT 26 0.0082
77 DRUG INTERACTION 1305 0.0082
78 APTYALISM 7 0.0082
79 PARANASAL SINUS HYPERSECRETION 31 0.0081
80 ILLNESS 835 0.0081
81 TONGUE DRY 11 0.0081
82 TONGUE BLISTERING 18 0.0081
83 PRODUCT COMMUNICATION ISSUE 71 0.0080
84 THERAPEUTIC RESPONSE UNEXPECTED 361 0.0080
85 NASAL PRURITUS 10 0.0080
86 MOUTH SWELLING 46 0.0080
87 WRONG DOSE 19 0.0079
88 OROPHARYNGEAL DISCOMFORT 70 0.0077
89 LIP BLISTER 21 0.0077
90 TRANSCRIPTION MEDICATION ERROR 12 0.0077
91 INCORRECT DOSAGE ADMINISTERED 37 0.0076
92 INCORRECT DOSE ADMINISTERED 1722 0.0075
93 PHARYNGEAL HYPOAESTHESIA 7 0.0075
94 PULMONARY PAIN 22 0.0075
95 DYSENTERY 14 0.0075
96 DIARRHOEA HAEMORRHAGIC 70 0.0075
97 TONGUE DISORDER 53 0.0073
98 COUGH 2051 0.0073
99 LEUKOCYTURIA 6 0.0073
100 THROAT TIGHTNESS 193 0.0071
101 EXPOSURE TO SARS-COV-2 12 0.0071
102 EXPIRED PRODUCT ADMINISTERED 234 0.0070
103 DRUG LEVEL ABOVE THERAPEUTIC 32 0.0070
104 PHARYNGEAL DISORDER 20 0.0069
105 PRODUCT PRESCRIBING ISSUE 148 0.0068
106 ANAL HAEMORRHAGE 19 0.0068
107 LIP EXFOLIATION 9 0.0068
108 BRAIN FOG 106 0.0068
109 OROPHARYNGEAL BLISTERING 11 0.0067
110 HAEMATOMA MUSCLE 8 0.0067
111 EAR CONGESTION 18 0.0066
112 SUSPECTED OFF LABEL USE 30 0.0066
113 HYPOGEUSIA 13 0.0066
114 EAR DISCOMFORT 68 0.0066
115 PRODUCT DISPENSING ISSUE 28 0.0065
116 REACTION TO EXCIPIENT 15 0.0065
117 PRODUCT LABEL ISSUE 44 0.0065
118 FEEDING DISORDER 131 0.0065
119 DRY THROAT 65 0.0064
120 PROCTALGIA 41 0.0064
121 DYSPHONIA 368 0.0063
122 FAECES DISCOLOURED 136 0.0063
123 DIARRHOEA 4041 0.0063
124 NASAL OEDEMA 11 0.0061
125 HEPATIC PAIN 26 0.0061
126 OESOPHAGEAL PAIN 24 0.0061
127 PHARYNGEAL ULCERATION 8 0.0060
128 RENAL PAIN 64 0.0060
129 COVID-19 PNEUMONIA 71 0.0060
130 GASTROINTESTINAL PAIN 66 0.0060
131 PRODUCT PACKAGING ISSUE 57 0.0060
132 TONGUE HAEMORRHAGE 7 0.0060
133 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 8 0.0059
134 LIP PAIN 17 0.0059
135 ORAL DISCOMFORT 82 0.0059
136 LIP DISORDER 11 0.0058
137 PHARYNGEAL INFLAMMATION 7 0.0058
138 THROAT IRRITATION 258 0.0057
139 MAST CELL ACTIVATION SYNDROME 8 0.0057
140 SLEEP DEFICIT 12 0.0057
141 NASAL DISORDER 15 0.0056
142 PARAESTHESIA ORAL 80 0.0055
143 ANORECTAL DISORDER 11 0.0055
144 RETCHING 116 0.0054
145 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 6 0.0054
146 LYMPH NODE PAIN 10 0.0054
147 POSTMENOPAUSAL HAEMORRHAGE 14 0.0054
148 DRUG CLEARANCE DECREASED 7 0.0054
149 ORAL PRURITUS 12 0.0052
150 CHROMATURIA 118 0.0052
151 SINUS HEADACHE 31 0.0052
152 ORAL MUCOSAL ERUPTION 8 0.0052
153 HEAD DISCOMFORT 92 0.0052
154 GLYCOSURIA 7 0.0052
155 HYPOAESTHESIA ORAL 78 0.0052
156 EAR PAIN 100 0.0051
157 ENERGY INCREASED 30 0.0051
158 GLOSSITIS 18 0.0051
159 PHYSICAL PRODUCT LABEL ISSUE 6 0.0050
160 ODYNOPHAGIA 30 0.0050
161 APHONIA 69 0.0049
162 SINUS NODE DYSFUNCTION 9 0.0049
163 GENITAL RASH 7 0.0049
164 BODY TEMPERATURE ABNORMAL 9 0.0049
165 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 165 0.0049
166 NONINFECTIVE GINGIVITIS 7 0.0048
167 PRODUCTIVE COUGH 230 0.0048
168 FAECES SOFT 35 0.0048
169 DRY MOUTH 389 0.0048
170 RHINALGIA 13 0.0047
171 PHARYNGEAL ERYTHEMA 10 0.0047
172 LIP SWELLING 155 0.0046
173 SECRETION DISCHARGE 58 0.0046
174 COUNTERFEIT PRODUCT ADMINISTERED 6 0.0046
175 INFUSION SITE DISCHARGE 8 0.0046
176 SUSPECTED COUNTERFEIT PRODUCT 18 0.0045
177 ORAL MUCOSAL ERYTHEMA 7 0.0045
178 PRODUCT COLOUR ISSUE 23 0.0045
179 POTENTIATING DRUG INTERACTION 15 0.0045
180 NASAL DISCHARGE DISCOLOURATION 6 0.0043
181 YELLOW SKIN 20 0.0043
182 EAR SWELLING 9 0.0042
183 AUDITORY DISORDER 6 0.0042
184 FIBRIN D DIMER INCREASED 15 0.0042
185 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 759 0.0042
186 DYSPHAGIA 398 0.0042
187 NASAL DISCOMFORT 33 0.0042
188 SWOLLEN TONGUE 130 0.0042
189 SPUTUM INCREASED 9 0.0042
190 ABNORMAL FAECES 34 0.0041
191 ORAL DISORDER 30 0.0041
192 COLD SWEAT 72 0.0041
193 FEELING ABNORMAL 970 0.0040
194 TEMPERATURE REGULATION DISORDER 9 0.0040
195 ABDOMINAL DISCOMFORT 667 0.0040
196 MIDDLE INSOMNIA 74 0.0040
197 ABDOMINAL PAIN UPPER 815 0.0040
198 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 6 0.0039
199 INTENTIONAL PRODUCT MISUSE 337 0.0038
200 URINARY HESITATION 9 0.0038
201 POOR QUALITY SLEEP 81 0.0038
202 WRONG PRODUCT ADMINISTERED 25 0.0037
203 SINUS DISORDER 73 0.0037
204 HICCUPS 30 0.0037
205 BRADYCARDIA 193 0.0036
206 PYREXIA 1256 0.0036
207 GINGIVAL SWELLING 16 0.0036
208 ARTHROPOD STING 6 0.0036
209 HEART RATE DECREASED 125 0.0036
210 SENSATION OF FOREIGN BODY 30 0.0036
211 DISTRIBUTIVE SHOCK 8 0.0035
212 OXYGEN SATURATION ABNORMAL 10 0.0035
213 CHILLS 410 0.0035
214 BLOOD CHLORIDE DECREASED 9 0.0035
215 HEADACHE 2182 0.0035
216 ACUTE SINUSITIS 6 0.0035
217 PANIC REACTION 25 0.0035
218 OCULAR ICTERUS 15 0.0035
219 PRESYNCOPE 84 0.0035
220 TINNITUS 158 0.0034
221 SPUTUM DISCOLOURED 32 0.0034
222 ANAL PRURITUS 7 0.0034
223 SINUS OPERATION 8 0.0034
224 NIGHT SWEATS 108 0.0033
225 NAUSEA 2646 0.0033
226 DRUG MONITORING PROCEDURE NOT PERFORMED 6 0.0033
227 EATING DISORDER 71 0.0033
228 APPETITE DISORDER 22 0.0033
229 PRODUCT USE ISSUE 619 0.0033
230 INSOMNIA 871 0.0033
231 ORAL PAIN 73 0.0033
232 PERIORBITAL SWELLING 18 0.0032
233 THROMBOTIC MICROANGIOPATHY 31 0.0032
234 MALAISE 1380 0.0031
235 EAR PRURITUS 11 0.0031
236 PRODUCT ADMINISTRATION ERROR 63 0.0031
237 CONVERSION DISORDER 6 0.0031
238 COMPLICATIONS OF TRANSPLANTED KIDNEY 7 0.0031
239 DEAFNESS UNILATERAL 17 0.0031
240 EPIGASTRIC DISCOMFORT 12 0.0031
241 HAEMORRHOIDAL HAEMORRHAGE 15 0.0031
242 URINE OUTPUT INCREASED 8 0.0031
243 BODY TEMPERATURE INCREASED 62 0.0030
244 SWELLING OF EYELID 19 0.0030
245 MYALGIA 513 0.0030
246 VOMITING 1413 0.0030
247 HORDEOLUM 13 0.0030
248 SALIVARY HYPERSECRETION 30 0.0030
249 GLOSSODYNIA 67 0.0030
250 MIXED LIVER INJURY 9 0.0030
251 PRODUCT ADMINISTRATION INTERRUPTED 23 0.0029
252 INITIAL INSOMNIA 30 0.0029
253 FACIAL PAIN 26 0.0029
254 REGURGITATION 10 0.0029
255 THIRST 52 0.0029
256 MICTURITION DISORDER 10 0.0029
257 BODY TEMPERATURE FLUCTUATION 6 0.0029
258 ERUCTATION 55 0.0028
259 ATRIOVENTRICULAR BLOCK COMPLETE 19 0.0028
260 DYSPEPSIA 279 0.0028
261 CHEST DISCOMFORT 290 0.0028
262 GASTROINTESTINAL SOUNDS ABNORMAL 14 0.0028
263 HEPATIC CYTOLYSIS 36 0.0028
264 ACCIDENTAL OVERDOSE 103 0.0028
265 PULMONARY CONGESTION 37 0.0028
266 ANAL INCONTINENCE 25 0.0028
267 CHEILITIS 15 0.0028
268 NASOPHARYNGITIS 508 0.0028
269 URTICARIA 461 0.0027
270 DECREASED APPETITE 638 0.0027
271 BODY TEMPERATURE DECREASED 27 0.0027
272 LISTLESS 9 0.0027
273 CORONAVIRUS INFECTION 18 0.0027
274 NASAL DRYNESS 17 0.0027
275 HYPERACUSIS 10 0.0027
276 THINKING ABNORMAL 50 0.0027
277 PRODUCT PACKAGING DIFFICULT TO OPEN 7 0.0027
278 GASTRIC DISORDER 91 0.0026
279 PULSELESS ELECTRICAL ACTIVITY 11 0.0026
280 URINE OUTPUT DECREASED 23 0.0026
281 EAR DISORDER 12 0.0026
282 BOWEL MOVEMENT IRREGULARITY 20 0.0026
283 RHINITIS 21 0.0026
284 FUNCTIONAL GASTROINTESTINAL DISORDER 9 0.0026
285 TACHYPHRENIA 9 0.0026
286 FATIGUE 2016 0.0026
287 ABDOMINAL RIGIDITY 7 0.0026
288 DIZZINESS POSTURAL 25 0.0026
289 NONSPECIFIC REACTION 14 0.0025
290 SKIN ODOUR ABNORMAL 10 0.0025
291 EUPHORIC MOOD 26 0.0025
292 RESTLESS LEGS SYNDROME 46 0.0025
293 GINGIVAL PAIN 20 0.0025
294 ELECTRIC SHOCK SENSATION 7 0.0025
295 HAEMATOCHEZIA 137 0.0025
296 GASTROOESOPHAGEAL REFLUX DISEASE 198 0.0025
297 ACUTE KIDNEY INJURY 374 0.0024
298 DYSSTASIA 71 0.0024
299 IMMUNE SYSTEM DISORDER 32 0.0024
300 BLOOD PRESSURE SYSTOLIC ABNORMAL 6 0.0024
301 MUCOUS STOOLS 12 0.0024
302 BLOOD IMMUNOGLOBULIN G DECREASED 6 0.0024
303 DIZZINESS 1206 0.0024
304 MUSCLE TIGHTNESS 39 0.0024
305 SKIN WARM 14 0.0024
306 LYMPHADENOPATHY 85 0.0024
307 FLUID INTAKE REDUCED 12 0.0024
308 HYPERHIDROSIS 308 0.0024
309 FEELING OF BODY TEMPERATURE CHANGE 14 0.0024
310 URINE ODOUR ABNORMAL 14 0.0024
311 TOOTHACHE 43 0.0024
312 RASH PRURITIC 128 0.0024
313 HEPATITIS FULMINANT 7 0.0024
314 LIPASE INCREASED 18 0.0023
315 VERTIGO 143 0.0023
316 BLOOD SODIUM DECREASED 44 0.0023
317 HYPONATRAEMIA 131 0.0023
318 ATRIOVENTRICULAR BLOCK SECOND DEGREE 7 0.0023
319 CHOKING 45 0.0023
320 ORAL HERPES 45 0.0023
321 GASTROINTESTINAL DISORDER 205 0.0023
322 RASH VESICULAR 11 0.0023
323 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 455 0.0022
324 HYPERCHLORHYDRIA 13 0.0022
325 ORAL CANDIDIASIS 29 0.0022
326 MUSCULOSKELETAL CHEST PAIN 34 0.0022
327 RASH ERYTHEMATOUS 105 0.0022
328 HYPERAESTHESIA 18 0.0022
329 CHOKING SENSATION 12 0.0022
330 FLATULENCE 123 0.0022
331 ABDOMINAL PAIN 504 0.0022
332 HEART RATE ABNORMAL 12 0.0021
333 LACRIMATION INCREASED 65 0.0021
334 INCREASED UPPER AIRWAY SECRETION 11 0.0021
335 MUSCLE FATIGUE 9 0.0021
336 NERVOUSNESS 111 0.0021
337 DEHYDRATION 283 0.0021
338 SINUSITIS 217 0.0021
339 BURNING SENSATION 148 0.0021
340 THERAPY CESSATION 108 0.0021
341 ABNORMAL DREAMS 58 0.0021
342 MUSCLE DISORDER 17 0.0021
343 TENSION HEADACHE 9 0.0021
344 PALPITATIONS 244 0.0021
345 GINGIVAL DISORDER 8 0.0021
346 HEART RATE INCREASED 206 0.0021
347 BLOOD PRESSURE INCREASED 317 0.0021
348 HYPOPHAGIA 53 0.0021
349 PNEUMONIA BACTERIAL 19 0.0021
350 DISORIENTATION 82 0.0021
351 HYPERTENSIVE CRISIS 23 0.0021
352 GAIT INABILITY 69 0.0021
353 HYPERSOMNIA 59 0.0021
354 PHOTOPSIA 13 0.0021
355 FEELING HOT 126 0.0021
356 SEASONAL ALLERGY 29 0.0020
357 DISCOMFORT 125 0.0020
358 SPEECH DISORDER 107 0.0020
359 INTENTIONAL DOSE OMISSION 58 0.0020
360 RECTAL HAEMORRHAGE 86 0.0020
361 HAEMORRHOIDS 39 0.0020
362 FEELING JITTERY 38 0.0020
363 SLEEP DISORDER 140 0.0020
364 BLOOD PRESSURE SYSTOLIC DECREASED 9 0.0020
365 INTERNATIONAL NORMALISED RATIO DECREASED 8 0.0020
366 OXYGEN SATURATION DECREASED 110 0.0020
367 CARDIOGENIC SHOCK 28 0.0019
368 NIGHTMARE 67 0.0019
369 ROSACEA 9 0.0019
370 FEELING OF DESPAIR 9 0.0019
371 HYPERTENSION 408 0.0019
372 BLOOD BLISTER 6 0.0019
373 ENCEPHALOPATHY 47 0.0019
374 INFUSION SITE PRURITUS 6 0.0019
375 HALLUCINATION, VISUAL 40 0.0019
376 HEAVY MENSTRUAL BLEEDING 17 0.0019
377 SWELLING FACE 123 0.0019
378 ASTHENIA 710 0.0019
379 IMPAIRED QUALITY OF LIFE 27 0.0019
380 RESPIRATORY DISORDER 56 0.0019
381 GLOMERULAR FILTRATION RATE DECREASED 23 0.0019
382 POLLAKIURIA 78 0.0019
383 GUILLAIN-BARRE SYNDROME 9 0.0019
384 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 19 0.0018
385 BLOOD URINE PRESENT 35 0.0018
386 MONOPLEGIA 8 0.0018
387 CONJUNCTIVAL HAEMORRHAGE 7 0.0018
388 GINGIVAL BLEEDING 25 0.0018
389 DEAFNESS NEUROSENSORY 6 0.0018
390 OESOPHAGEAL ULCER 7 0.0018
391 OESOPHAGEAL DISORDER 7 0.0018
392 BLOOD CREATINE INCREASED 8 0.0018
393 APHTHOUS ULCER 14 0.0018
394 FAECES HARD 7 0.0018
395 RASH PAPULAR 40 0.0018
396 NEPHROPATHY TOXIC 20 0.0018
397 BODY HEIGHT DECREASED 19 0.0018
398 TOXIC ENCEPHALOPATHY 9 0.0018
399 HYPOACUSIS 76 0.0018
400 SLUGGISHNESS 18 0.0018
401 SYNCOPE 176 0.0018
402 SINUS BRADYCARDIA 17 0.0018
403 CEREBRAL DISORDER 13 0.0018
404 TOXICITY TO VARIOUS AGENTS 294 0.0017
405 RESPIRATION ABNORMAL 12 0.0017
406 PAIN 1065 0.0017
407 FORMICATION 12 0.0017
408 RASH 750 0.0017
409 SEROTONIN SYNDROME 33 0.0017
410 MUSCLE SPASMS 315 0.0017
411 DEFAECATION URGENCY 12 0.0017
412 HALLUCINATION 129 0.0017
413 POLYURIA 14 0.0017
414 FLANK PAIN 16 0.0017
415 HANGOVER 6 0.0017
416 LETHARGY 98 0.0017
417 IMMUNOSUPPRESSION 15 0.0017
418 THERMAL BURN 12 0.0017
419 HYPOTHERMIA 17 0.0017
420 CONJUNCTIVITIS 31 0.0017
421 TREMOR 277 0.0017
422 SLEEP TERROR 7 0.0017
423 RASH MACULAR 58 0.0017
424 LIP OEDEMA 7 0.0017
425 BLOOD PHOSPHORUS DECREASED 6 0.0016
426 MUSCULOSKELETAL DISCOMFORT 28 0.0016
427 BREATH SOUNDS ABNORMAL 8 0.0016
428 ABDOMINAL PAIN LOWER 41 0.0016
429 STREPTOCOCCAL INFECTION 9 0.0016
430 FEELING COLD 45 0.0016
431 FEELING DRUNK 12 0.0016
432 CHAPPED LIPS 7 0.0016
433 BLOOD PRESSURE DECREASED 106 0.0016
434 PRODUCT DOSE OMISSION IN ERROR 45 0.0016
435 LIVER FUNCTION TEST INCREASED 34 0.0016
436 ACIDOSIS 12 0.0016
437 HYPERSENSITIVITY 289 0.0016
438 FOOD ALLERGY 12 0.0016
439 ATRIOVENTRICULAR BLOCK 12 0.0016
440 CHEST PAIN 287 0.0015
441 TRISMUS 8 0.0015
442 HEART RATE IRREGULAR 35 0.0015
443 MENTAL STATUS CHANGES 43 0.0015
444 CARDIAC FLUTTER 10 0.0015
445 INCOHERENT 10 0.0015
446 IMMUNODEFICIENCY 23 0.0015
447 BLOOD THYROID STIMULATING HORMONE DECREASED 7 0.0015
448 MUSCLE RUPTURE 6 0.0015
449 AUTOIMMUNE DISORDER 15 0.0015
450 HEPATITIS ACUTE 10 0.0015
451 BLOOD PRESSURE SYSTOLIC INCREASED 30 0.0015
452 ACUTE HEPATIC FAILURE 21 0.0015
453 HYPOGAMMAGLOBULINAEMIA 10 0.0015
454 MOUTH ULCERATION 32 0.0015
455 BLOOD LACTIC ACID INCREASED 8 0.0015
456 BLOOD PRESSURE DIASTOLIC INCREASED 7 0.0015
457 OFF LABEL USE 1325 0.0015
458 BLOOD ALBUMIN DECREASED 12 0.0015
459 ANAL FISTULA 8 0.0015
460 PRURITUS 576 0.0015
461 MIGRAINE 143 0.0015
462 BLOOD UREA INCREASED 25 0.0015
463 POST-TRAUMATIC STRESS DISORDER 10 0.0015
464 EYE PRURITUS 50 0.0015
465 FRUSTRATION TOLERANCE DECREASED 12 0.0015
466 NEUROTOXICITY 26 0.0015
467 BALANCE DISORDER 128 0.0015
468 FREQUENT BOWEL MOVEMENTS 40 0.0015
469 BLISTER 83 0.0015
470 SUNBURN 11 0.0015
471 PULSE ABSENT 7 0.0015
472 STOMATITIS 89 0.0015
473 NECK PAIN 82 0.0015
474 LARYNGEAL OEDEMA 9 0.0015
475 BLOOD PRESSURE ABNORMAL 29 0.0015
476 ASTHENOPIA 8 0.0015
477 PANIC ATTACK 53 0.0015
478 CONDITION AGGRAVATED 441 0.0014
479 PROSTATIC DISORDER 8 0.0014
480 POOR VENOUS ACCESS 15 0.0014
481 IRRITABLE BOWEL SYNDROME 31 0.0014
482 TROPONIN INCREASED 11 0.0014
483 PRE-EXISTING CONDITION IMPROVED 9 0.0014
484 DELIRIUM 50 0.0014
485 NEURALGIA 35 0.0014
486 LOSS OF CONSCIOUSNESS 183 0.0014
487 EAR INFECTION 38 0.0014
488 HALLUCINATIONS, MIXED 6 0.0014
489 OCULAR DISCOMFORT 16 0.0014
490 ATTENTION DEFICIT HYPERACTIVITY DISORDER 6 0.0014
491 BLOOD CREATININE INCREASED 93 0.0014
492 DUODENAL ULCER 10 0.0014
493 EYE INFECTION 16 0.0014
494 DEAFNESS 37 0.0014
495 SCREAMING 9 0.0014
496 RENAL IMPAIRMENT 118 0.0014
497 MENTAL IMPAIRMENT 34 0.0014
498 VISION BLURRED 192 0.0014
499 HAEMOPTYSIS 39 0.0014
500 PHOTOSENSITIVITY REACTION 23 0.0014
501 PHARYNGITIS STREPTOCOCCAL 15 0.0014
502 PERIPHERAL COLDNESS 19 0.0014
503 PRODUCT DOSE OMISSION ISSUE 406 0.0014
504 HYPERVENTILATION 8 0.0014
505 MATERNAL EXPOSURE DURING PREGNANCY 123 0.0014
506 SENSORY DISTURBANCE 22 0.0014
507 BEDRIDDEN 18 0.0014
508 RESTLESSNESS 50 0.0014
509 PHYSICAL DISABILITY 6 0.0014
510 SENSITIVE SKIN 10 0.0014
511 DISTURBANCE IN ATTENTION 73 0.0014
512 DERMATITIS ALLERGIC 17 0.0014
513 STEVENS-JOHNSON SYNDROME 30 0.0013
514 URINARY RETENTION 45 0.0013
515 EYE DISCHARGE 14 0.0013
516 ILEUS PARALYTIC 6 0.0013
517 TONSILLITIS 7 0.0013
518 HAEMATEMESIS 34 0.0013
519 BRONCHITIS 99 0.0013
520 ASTHMA 151 0.0013
521 DYSURIA 49 0.0013
522 DYSPNOEA 751 0.0013
523 PSYCHOMOTOR HYPERACTIVITY 22 0.0013
524 HALLUCINATION, AUDITORY 21 0.0013
525 LIP DRY 12 0.0013
526 IMPAIRED GASTRIC EMPTYING 18 0.0013
527 MICTURITION URGENCY 15 0.0013
528 BREAST PAIN 14 0.0013
529 MOVEMENT DISORDER 42 0.0013
530 GASTROINTESTINAL MOTILITY DISORDER 7 0.0013
531 BUNDLE BRANCH BLOCK RIGHT 6 0.0013
532 BLOOD THYROID STIMULATING HORMONE INCREASED 12 0.0013
533 HAEMOLYSIS 10 0.0013
534 INTERCEPTED MEDICATION ERROR 6 0.0013
535 ELECTROLYTE IMBALANCE 15 0.0013
536 PRODUCT PHYSICAL ISSUE 26 0.0013
537 PHOTOPHOBIA 24 0.0013
538 CONFUSIONAL STATE 206 0.0013
539 MUSCLE STRAIN 11 0.0013
540 INTERMENSTRUAL BLEEDING 7 0.0013
541 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 60 0.0012
542 ABDOMINAL DISTENSION 130 0.0012
543 SENSORY LOSS 10 0.0012
544 PARAESTHESIA 195 0.0012
545 UPPER RESPIRATORY TRACT INFECTION 57 0.0012
546 LIMB DISCOMFORT 38 0.0012
547 HYPERKALAEMIA 43 0.0012
548 DYSPNOEA EXERTIONAL 46 0.0012
549 PRODUCT PREPARATION ISSUE 8 0.0012
550 BLOOD PRESSURE DIASTOLIC DECREASED 9 0.0012
551 SOMNAMBULISM 8 0.0012
552 MUSCLE TWITCHING 28 0.0012
553 ARTHROPOD BITE 9 0.0012
554 LIGAMENT SPRAIN 12 0.0012
555 ACUTE CORONARY SYNDROME 10 0.0012
556 RENAL DISORDER 56 0.0012
557 BACK PAIN 277 0.0012
558 EPISTAXIS 89 0.0012
559 WEIGHT DECREASED 332 0.0012
560 MUSCULAR WEAKNESS 135 0.0012
561 EYE PAIN 67 0.0012
562 BRADYKINESIA 7 0.0012
563 CANDIDA INFECTION 20 0.0012
564 EYE SWELLING 44 0.0012
565 LIVER INJURY 29 0.0012
566 HYPOTENSION 236 0.0012
567 FACIAL PARALYSIS 10 0.0012
568 EYE MOVEMENT DISORDER 8 0.0012
569 MULTIPLE ORGAN DYSFUNCTION SYNDROME 33 0.0012
570 ALANINE AMINOTRANSFERASE INCREASED 71 0.0012
571 HYPOAESTHESIA 172 0.0011
572 SOMNOLENCE 230 0.0011
573 MELAENA 25 0.0011
574 INCONTINENCE 12 0.0011
575 PAIN IN JAW 32 0.0011
576 CRYING 41 0.0011
577 EYE DISORDER 37 0.0011
578 TRANSAMINASES INCREASED 25 0.0011
579 EYE HAEMORRHAGE 15 0.0011
580 FOOD POISONING 6 0.0011
581 PARALYSIS 16 0.0011
582 CIRCULATORY COLLAPSE 19 0.0011
583 ERYTHEMA 229 0.0011
584 URINARY INCONTINENCE 33 0.0011
585 LIVER DISORDER 49 0.0011
586 MENTAL DISORDER 48 0.0011
587 PARANOIA 19 0.0011
588 PRODUCT PHYSICAL CONSISTENCY ISSUE 6 0.0011
589 BLOOD PRESSURE FLUCTUATION 26 0.0011
590 FEAR 29 0.0011
591 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 7 0.0011
592 DRUG ERUPTION 19 0.0011
593 APPENDICITIS 10 0.0011
594 BLOOD POTASSIUM DECREASED 32 0.0011
595 EXTRA DOSE ADMINISTERED 43 0.0011
596 VENTRICULAR EXTRASYSTOLES 11 0.0011
597 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 31 0.0011
598 ASPARTATE AMINOTRANSFERASE INCREASED 56 0.0011
599 ANXIETY 298 0.0010
600 DISSOCIATION 8 0.0010
601 WHITE BLOOD CELL COUNT INCREASED 40 0.0010
602 JAUNDICE 28 0.0010
603 TACHYCARDIA 92 0.0010
604 ARRHYTHMIA 49 0.0010
605 RASH MACULO-PAPULAR 23 0.0010
606 PERIPHERAL SENSORY NEUROPATHY 6 0.0010
607 PANCREATITIS ACUTE 23 0.0010
608 INFLUENZA LIKE ILLNESS 84 0.0010
609 MULTIPLE ALLERGIES 8 0.0010
610 SKIN LACERATION 11 0.0010
611 HEAD INJURY 32 0.0010
612 DIVERTICULITIS 28 0.0010
613 PULMONARY THROMBOSIS 11 0.0010
614 HYPERTRANSAMINASAEMIA 7 0.0010
615 ANGIOEDEMA 44 0.0010
616 HYPOXIA 35 0.0010
617 EYE IRRITATION 57 0.0010
618 NOCTURIA 12 0.0010
619 PATHOGEN RESISTANCE 9 0.0010
620 DERMATITIS ACNEIFORM 6 0.0010
621 LUNG DISORDER 48 0.0010
622 INCREASED TENDENCY TO BRUISE 9 0.0010
623 HEPATITIS 25 0.0010
624 MENISCUS INJURY 6 0.0010
625 MANIA 16 0.0010
626 METABOLIC ACIDOSIS 31 0.0010
627 HOT FLUSH 73 0.0010
628 THERAPY INTERRUPTED 69 0.0010
629 ATRIAL FIBRILLATION 94 0.0010
630 DIPLOPIA 25 0.0010
631 WHEEZING 57 0.0010
632 INFUSION SITE SWELLING 6 0.0010
633 GASTRITIS 25 0.0009
634 GOUT 17 0.0009
635 HYPOPHOSPHATAEMIA 7 0.0009
636 GAIT DISTURBANCE 181 0.0009
637 BLOOD CREATINE PHOSPHOKINASE INCREASED 27 0.0009
638 SWELLING 87 0.0009
639 ANURIA 8 0.0009
640 OCULAR HYPERAEMIA 44 0.0009
641 HIATUS HERNIA 12 0.0009
642 ALTERED STATE OF CONSCIOUSNESS 20 0.0009
643 BRADYPHRENIA 6 0.0009
644 VITREOUS FLOATERS 9 0.0009
645 INTERCEPTED PRODUCT ADMINISTRATION ERROR 7 0.0009
646 HEPATIC FUNCTION ABNORMAL 34 0.0009
647 DYSGRAPHIA 6 0.0009
648 PRODUCT FORMULATION ISSUE 6 0.0009
649 PAIN IN EXTREMITY 266 0.0009
650 DELUSION 14 0.0009
651 COGNITIVE DISORDER 42 0.0009
652 MUSCLE SPASTICITY 11 0.0009
653 DRUG-INDUCED LIVER INJURY 28 0.0009
654 EMPHYSEMA 9 0.0009
655 ELECTROCARDIOGRAM QT PROLONGED 32 0.0009
656 PANCREATITIS 47 0.0009
657 PULMONARY FIBROSIS 17 0.0009
658 SCIATICA 14 0.0009
659 AGITATION 64 0.0009
660 COLITIS 33 0.0009
661 ANAPHYLACTIC REACTION 48 0.0009
662 VISUAL IMPAIRMENT 107 0.0009
663 ORTHOSTATIC HYPOTENSION 15 0.0009
664 PRODUCT ODOUR ABNORMAL 9 0.0009
665 SPINAL PAIN 10 0.0009
666 SKIN DISCOLOURATION 39 0.0008
667 CONSTIPATION 185 0.0008
668 DIVERTICULUM 6 0.0008
669 COAGULOPATHY 14 0.0008
670 RHABDOMYOLYSIS 35 0.0008
671 JOINT RANGE OF MOTION DECREASED 11 0.0008
672 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 14 0.0008
673 SMALL INTESTINAL OBSTRUCTION 10 0.0008
674 EMOTIONAL DISORDER 25 0.0008
675 ARTHRALGIA 336 0.0008
676 PYELONEPHRITIS 7 0.0008
677 AGRANULOCYTOSIS 15 0.0008
678 HEPATIC ENZYME INCREASED 55 0.0008
679 INTERNATIONAL NORMALISED RATIO INCREASED 23 0.0008
680 BLOOD ALKALINE PHOSPHATASE INCREASED 20 0.0008
681 BACTERIAL INFECTION 15 0.0008
682 BACK DISORDER 13 0.0008
683 MEMORY IMPAIRMENT 109 0.0008
684 LYMPHOCYTE COUNT DECREASED 14 0.0008
685 TOXIC EPIDERMAL NECROLYSIS 12 0.0008
686 HYPOMAGNESAEMIA 11 0.0008
687 HUNGER 11 0.0008
688 SLEEP APNOEA SYNDROME 15 0.0008
689 SHOCK 18 0.0008
690 SKIN REACTION 11 0.0008
691 SKIN DISORDER 26 0.0008
692 BRONCHOPULMONARY ASPERGILLOSIS 6 0.0008
693 PALLOR 21 0.0008
694 BRONCHOSPASM 11 0.0008
695 RESPIRATORY TRACT INFECTION 20 0.0008
696 TENDERNESS 8 0.0008
697 PERIPHERAL SWELLING 118 0.0008
698 APHASIA 23 0.0008
699 BLOOD IRON DECREASED 9 0.0008
700 BLOOD GLUCOSE DECREASED 36 0.0007
701 BLOOD DISORDER 6 0.0007
702 LACTIC ACIDOSIS 24 0.0007
703 TACHYPNOEA 10 0.0007
704 CYTOPENIA 9 0.0007
705 ASPHYXIA 6 0.0007
706 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
707 HAEMORRHAGE 76 0.0007
708 VENTRICULAR TACHYCARDIA 12 0.0007
709 INFLUENZA 81 0.0007
710 ILEUS 9 0.0007
711 MOBILITY DECREASED 52 0.0007
712 DENTAL CARIES 8 0.0007
713 PNEUMONIA ASPIRATION 18 0.0007
714 POISONING 9 0.0007
715 URINARY TRACT INFECTION 122 0.0007
716 MALNUTRITION 8 0.0007
717 COELIAC DISEASE 7 0.0007
718 DECREASED IMMUNE RESPONSIVENESS 7 0.0007
719 EJECTION FRACTION DECREASED 11 0.0007
720 HAEMATOCRIT DECREASED 14 0.0007
721 RED BLOOD CELL COUNT DECREASED 20 0.0007
722 SKIN EXFOLIATION 59 0.0007
723 ANGINA PECTORIS 20 0.0007
724 BLOOD MAGNESIUM DECREASED 6 0.0007
725 VAGINAL DISCHARGE 7 0.0007
726 BLOOD GLUCOSE INCREASED 130 0.0007
727 C-REACTIVE PROTEIN INCREASED 25 0.0007
728 MUSCULOSKELETAL STIFFNESS 60 0.0007
729 GROIN PAIN 6 0.0007
730 IRRITABILITY 41 0.0007
731 GRIP STRENGTH DECREASED 6 0.0007
732 PNEUMONIA 220 0.0007
733 BLOOD POTASSIUM INCREASED 11 0.0007
734 PSYCHOTIC DISORDER 20 0.0007
735 GAMMA-GLUTAMYLTRANSFERASE INCREASED 15 0.0007
736 ATAXIA 8 0.0007
737 CARDIAC DISORDER 63 0.0007
738 HYPOKALAEMIA 31 0.0007
739 CHOLECYSTITIS 8 0.0007
740 DIABETIC KETOACIDOSIS 16 0.0007
741 GENERALISED TONIC-CLONIC SEIZURE 11 0.0007
742 FUNGAL INFECTION 22 0.0007
743 UNRESPONSIVE TO STIMULI 17 0.0007
744 NEPHROLITHIASIS 30 0.0007
745 INTENTIONAL PRODUCT USE ISSUE 57 0.0007
746 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 11 0.0006
747 HEPATIC ENCEPHALOPATHY 6 0.0006
748 BLOOD TEST ABNORMAL 9 0.0006
749 ASPIRATION 7 0.0006
750 DYSARTHRIA 24 0.0006
751 LEUKAEMIA 6 0.0006
752 BLOOD LACTATE DEHYDROGENASE INCREASED 10 0.0006
753 AMNESIA 41 0.0006
754 NERVE INJURY 7 0.0006
755 OBSTRUCTIVE AIRWAYS DISORDER 7 0.0006
756 HERPES ZOSTER 36 0.0006
757 LIMB INJURY 17 0.0006
758 ANGER 21 0.0006
759 HYPOKINESIA 9 0.0006
760 FLUSHING 63 0.0006
761 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 34 0.0006
762 DERMATITIS CONTACT 7 0.0006
763 PLATELET COUNT INCREASED 8 0.0006
764 FALL 204 0.0006
765 KIDNEY INFECTION 12 0.0006
766 MYOCARDITIS 7 0.0006
767 IMPAIRED WORK ABILITY 13 0.0006
768 ANKYLOSING SPONDYLITIS 8 0.0006
769 MULTIPLE SCLEROSIS 29 0.0006
770 SEIZURE 70 0.0006
771 HYPERGLYCAEMIA 22 0.0006
772 INFLAMMATION 31 0.0006
773 MALIGNANT MELANOMA 8 0.0006
774 CYSTITIS 19 0.0006
775 PERICARDITIS 10 0.0006
776 RENAL FAILURE 79 0.0006
777 PAIN OF SKIN 16 0.0006
778 PRODUCT COMPLAINT 15 0.0006
779 HEPATIC STEATOSIS 11 0.0006
780 DYSKINESIA 24 0.0006
781 EYELID PTOSIS 6 0.0006
782 MYOCLONUS 7 0.0006
783 MACULAR DEGENERATION 7 0.0006
784 NEUTROPHIL COUNT INCREASED 6 0.0006
785 LIVER FUNCTION TEST ABNORMAL 17 0.0006
786 DRY EYE 29 0.0006
787 RESPIRATORY DISTRESS 16 0.0006
788 CHOLELITHIASIS 19 0.0006
789 NERVOUS SYSTEM DISORDER 18 0.0006
790 RESPIRATORY FAILURE 42 0.0006
791 COORDINATION ABNORMAL 8 0.0006
792 INFUSION RELATED REACTION 38 0.0006
793 DEMENTIA 16 0.0006
794 CONTUSION 55 0.0006
795 FULL BLOOD COUNT ABNORMAL 6 0.0006
796 LYMPHOPENIA 8 0.0006
797 PHARYNGITIS 7 0.0006
798 INFECTION 81 0.0006
799 DECREASED ACTIVITY 6 0.0006
800 DEPRESSED LEVEL OF CONSCIOUSNESS 22 0.0006
801 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 29 0.0006
802 MENSTRUATION DELAYED 6 0.0006
803 LEUKOCYTOSIS 10 0.0006
804 MUSCLE ATROPHY 7 0.0006
805 SEPTIC SHOCK 24 0.0006
806 OESOPHAGITIS 6 0.0005
807 ROTATOR CUFF SYNDROME 7 0.0005
808 INFUSION SITE PAIN 7 0.0005
809 BLINDNESS 22 0.0005
810 DRUG EFFECT LESS THAN EXPECTED 8 0.0005
811 TOOTH DISORDER 12 0.0005
812 PULMONARY MASS 8 0.0005
813 SEDATION 14 0.0005
814 THROMBOSIS 43 0.0005
815 JOINT STIFFNESS 14 0.0005
816 MITRAL VALVE INCOMPETENCE 6 0.0005
817 DYSMENORRHOEA 7 0.0005
818 IMPAIRED DRIVING ABILITY 6 0.0005
819 GASTRIC ULCER 10 0.0005
820 SCAR 9 0.0005
821 INCREASED APPETITE 10 0.0005
822 ADVERSE DRUG REACTION 47 0.0005
823 MENSTRUATION IRREGULAR 14 0.0005
824 NEUROPATHY PERIPHERAL 49 0.0005
825 NEUTROPENIA 70 0.0005
826 MOOD ALTERED 14 0.0005
827 BONE PAIN 30 0.0005
828 VIRAL INFECTION 17 0.0005
829 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
830 CYANOSIS 8 0.0005
831 HYPERLIPIDAEMIA 6 0.0005
832 EXPOSURE DURING PREGNANCY 31 0.0005
833 DIABETES MELLITUS 38 0.0005
834 HAEMATURIA 17 0.0005
835 BLOOD CHOLESTEROL INCREASED 23 0.0005
836 SINUS TACHYCARDIA 7 0.0005
837 CARDIOMEGALY 6 0.0005
838 ACCIDENTAL UNDERDOSE 7 0.0005
839 LOWER RESPIRATORY TRACT INFECTION 22 0.0005
840 BLOOD BILIRUBIN INCREASED 13 0.0005
841 ECZEMA 25 0.0005
842 TRANSIENT ISCHAEMIC ATTACK 16 0.0005
843 INTRAOCULAR PRESSURE INCREASED 6 0.0005
844 CHOLESTASIS 9 0.0005
845 ANAPHYLACTIC SHOCK 12 0.0005
846 ECONOMIC PROBLEM 7 0.0005
847 OSTEOPENIA 7 0.0005
848 INSURANCE ISSUE 7 0.0005
849 JOINT SWELLING 55 0.0005
850 DISABILITY 9 0.0005
851 PHARYNGEAL OEDEMA 7 0.0005
852 UNDERDOSE 33 0.0005
853 UPPER LIMB FRACTURE 9 0.0005
854 PANCYTOPENIA 25 0.0004
855 SKIN BURNING SENSATION 32 0.0004
856 OVERDOSE 96 0.0004
857 DEPRESSION 101 0.0004
858 NEUTROPHIL COUNT DECREASED 18 0.0004
859 ACUTE MYOCARDIAL INFARCTION 13 0.0004
860 PNEUMONITIS 12 0.0004
861 RENAL INJURY 13 0.0004
862 HIP FRACTURE 14 0.0004
863 DEPRESSED MOOD 23 0.0004
864 DRUG INTOLERANCE 42 0.0004
865 CARDIOVASCULAR DISORDER 11 0.0004
866 KNEE ARTHROPLASTY 9 0.0004
867 CARDIAC ARREST 35 0.0004
868 HEPATOCELLULAR INJURY 6 0.0004
869 DIALYSIS 6 0.0004
870 SYSTEMIC LUPUS ERYTHEMATOSUS 15 0.0004
871 COMA 20 0.0004
872 GASTROINTESTINAL HAEMORRHAGE 35 0.0004
873 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
874 FACE OEDEMA 7 0.0004
875 ARTHROPATHY 23 0.0004
876 ARTHRITIS 32 0.0004
877 GENERAL PHYSICAL HEALTH DETERIORATION 47 0.0004
878 CARDIOMYOPATHY 6 0.0004
879 CYTOKINE RELEASE SYNDROME 8 0.0004
880 CARDIAC FAILURE 32 0.0004
881 HEPATIC FAILURE 12 0.0004
882 PRODUCT AVAILABILITY ISSUE 9 0.0004
883 PLEURAL EFFUSION 24 0.0004
884 EPILEPSY 12 0.0004
885 ISCHAEMIC STROKE 7 0.0004
886 PRODUCT PREPARATION ERROR 8 0.0004
887 WHITE BLOOD CELL COUNT DECREASED 42 0.0004
888 THROMBOCYTOPENIA 43 0.0004
889 PULMONARY EMBOLISM 36 0.0004
890 JOINT INJURY 8 0.0004
891 NEOPLASM PROGRESSION 13 0.0004
892 FLUID RETENTION 19 0.0004
893 CEREBROVASCULAR ACCIDENT 63 0.0004
894 INTESTINAL OBSTRUCTION 14 0.0004
895 FIBROMYALGIA 9 0.0004
896 HAEMOGLOBIN DECREASED 38 0.0004
897 VAGINAL HAEMORRHAGE 16 0.0004
898 DRUG INEFFECTIVE 483 0.0004
899 SKIN LESION 10 0.0004
900 PULMONARY OEDEMA 16 0.0004
901 THERAPEUTIC PRODUCT EFFECT DECREASED 16 0.0004
902 WITHDRAWAL SYNDROME 15 0.0004
903 HEMIPARESIS 6 0.0004
904 DRUG RESISTANCE 9 0.0004
905 SUICIDAL IDEATION 32 0.0003
906 FULL BLOOD COUNT DECREASED 7 0.0003
907 HYPOTHYROIDISM 11 0.0003
908 MUCOSAL INFLAMMATION 9 0.0003
909 MUSCULOSKELETAL PAIN 18 0.0003
910 RIB FRACTURE 7 0.0003
911 GALLBLADDER DISORDER 6 0.0003
912 DERMATITIS 7 0.0003
913 GASTROENTERITIS VIRAL 6 0.0003
914 THERAPEUTIC RESPONSE SHORTENED 11 0.0003
915 BONE DISORDER 6 0.0003
916 SKIN CANCER 7 0.0003
917 AGGRESSION 16 0.0003
918 MUSCULOSKELETAL DISORDER 6 0.0003
919 HEPATOTOXICITY 7 0.0003
920 SEPSIS 35 0.0003
921 COLITIS ULCERATIVE 14 0.0003
922 ACUTE RESPIRATORY FAILURE 6 0.0003
923 TREATMENT NONCOMPLIANCE 17 0.0003
924 HERNIA 6 0.0003
925 PRESCRIBED OVERDOSE 6 0.0003
926 PLATELET COUNT DECREASED 33 0.0003
927 DYSTONIA 6 0.0003
928 PRODUCT USE IN UNAPPROVED INDICATION 76 0.0003
929 OSTEOARTHRITIS 13 0.0003
930 SKIN IRRITATION 14 0.0003
931 FEBRILE NEUTROPENIA 20 0.0003
932 LEUKOPENIA 15 0.0003
933 DRY SKIN 40 0.0003
934 NEOPLASM MALIGNANT 20 0.0003
935 RHEUMATOID ARTHRITIS 34 0.0003
936 PRODUCT STORAGE ERROR 26 0.0003
937 NO ADVERSE EVENT 53 0.0003
938 ACNE 22 0.0003
939 LOCALISED INFECTION 7 0.0003
940 PROCEDURAL PAIN 8 0.0003
941 MOOD SWINGS 9 0.0003
942 MYELOSUPPRESSION 10 0.0003
943 ABNORMAL BEHAVIOUR 11 0.0003
944 GLYCOSYLATED HAEMOGLOBIN INCREASED 7 0.0003
945 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
946 PSORIATIC ARTHROPATHY 11 0.0003
947 MEDICATION ERROR 15 0.0003
948 THERAPY NON-RESPONDER 12 0.0003
949 DEEP VEIN THROMBOSIS 17 0.0003
950 OEDEMA 14 0.0003
951 CELLULITIS 13 0.0003
952 ANAEMIA 49 0.0003
953 CATARACT 15 0.0003
954 UNEVALUABLE EVENT 19 0.0003
955 CHRONIC KIDNEY DISEASE 19 0.0002
956 CEREBRAL INFARCTION 6 0.0002
957 OSTEONECROSIS 8 0.0002
958 OSTEOPOROSIS 10 0.0002
959 EXTRAPYRAMIDAL DISORDER 6 0.0002
960 DEATH 208 0.0002
961 ALOPECIA 47 0.0002
962 OEDEMA PERIPHERAL 29 0.0002
963 WEIGHT INCREASED 53 0.0002
964 HAEMATOMA 6 0.0002
965 DISEASE PROGRESSION 27 0.0002
966 HYPOGLYCAEMIA 11 0.0002
967 CARDIAC FAILURE CONGESTIVE 18 0.0002
968 CEREBRAL HAEMORRHAGE 8 0.0002
969 CARDIO-RESPIRATORY ARREST 9 0.0002
970 ROAD TRAFFIC ACCIDENT 9 0.0002
971 ILL-DEFINED DISORDER 13 0.0002
972 MYOCARDIAL INFARCTION 37 0.0002
973 NEEDLE ISSUE 6 0.0002
974 INJURY 14 0.0002
975 CORONARY ARTERY DISEASE 6 0.0002
976 PSORIASIS 23 0.0002
977 EMOTIONAL DISTRESS 20 0.0002
978 SURGERY 9 0.0002
979 INJECTION SITE REACTION 10 0.0001
980 ADVERSE EVENT 13 0.0001
981 HOSPITALISATION 21 0.0001
982 MULTIPLE SCLEROSIS RELAPSE 9 0.0001
983 INJECTION SITE BRUISING 9 0.0001
984 PRODUCT QUALITY ISSUE 13 0.0001
985 INJECTION SITE SWELLING 7 0.0001
986 DRUG WITHDRAWAL SYNDROME 8 0.0001
987 INJECTION SITE PAIN 27 0.0001
988 TREATMENT FAILURE 7 0.0001
989 INJECTION SITE ERYTHEMA 10 0.0001